Compare
Thayer Ventures Acquisition Corp II vs Cantor Equity Partners I, Inc. vs NewHold Investment Corp. III vs Oaktree Acquisition Corp. III Life Sciences
| Latest fiscal year | Thayer Ventures Acquisition Corp II TVAI | Cantor Equity Partners I, Inc. CEPO | NewHold Investment Corp. III NHIC | Oaktree Acquisition Corp. III Life Sciences OACC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | n/a | n/a | n/a |
| Revenue growth (YoY) | n/a | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a | n/a |
| Net income | $3.88M | -$6.66M | $4.92M | $7.29M |
| EPS (Diluted) | n/a | n/a | n/a | n/a |
| Operating cash flow | $617.1K | $52.6K | -$1.01M | -$422.1K |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | $0 | n/a | $1.20M | $1.43M |
| Total assets | $206.82M | $207.73M | $210.55M | $203.11M |
| Total liabilities | $8.64M | $14.00M | $8.29M | $8.32M |
| Shareholders' equity | -$8.18M | -$16.78M | -$6.96M | -$6.77M |
| Return on year-end equity | n/a | n/a | n/a | n/a |
| Shares outstanding | n/a | n/a | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Thayer Ventures Acquisition Corp II | Cantor Equity Partners I, Inc. | NewHold Investment Corp. III | Oaktree Acquisition Corp. III Life Sciences |
|---|---|---|---|---|
| Latest | n/a | n/a | n/a | n/a |
| 1 year earlier | n/a | n/a | n/a | n/a |
| 2 years earlier | n/a | n/a | n/a | n/a |
| 3 years earlier | n/a | n/a | n/a | n/a |
| 4 years earlier | n/a | n/a | n/a | n/a |